AMA Rescinds Directive Against HCQ?!!
Ok, am I like the last person on earth to hear this, or is this news? A friend just sent me an article on it. Here’s one I found:
I also didn’t notice until my friend pointed out that this happened on October 30th, but has been kept quiet until now. Here’s the first few paragraphs:
“The American Medical Association has officially rescinded a previous statement against the use of Hydroxychloroquine (HCQ) in the treatment of COVID-19 patients. Physicians can use it at their discretion.
In March, the AMA had issued a statement that was highly critical of HCQ in regards to its use as a proposed treatment by some physicians in the early stages of COVID-19.
The AMA discouraged doctors from ordering the medication in bulk for “off-label” use. They use it for illnesses like malaria and rheumatoid arthritis.
The AMA also claimed that there was no proof that it was effective in treating COVID. They added it could be harmful in some instances.
As it happens, on page 18 of a recent AMA memo, issued on October 30 (resolution 509, page 3), the organization officially reversed its stance on HCQ. Now, they say its potential for good currently may supersede the threat of any potentially harmful side effects.”
Here’s the AMA’s language rescinding their directive against HCQ, per source.
RUFK? Nope, not political at all…
The AMA shows us how science is done. Ha! Charlatans and worse!
For people who want to check out the actual AMA Source document, you have to scroll down about 18 pages to get to Resolution 509, which is the one dealing with HCQ, “Hydroxychloroquine and Combination Therapies – Off-Label Use”
Ok, so now I’ve found an article implying all the other articles saying the AMA has rescinded its ban on HCQ have misinterpreted the report. The article implies that the resolution was put forth, but not approved.
After doing some more digging, I found this document from the AMA that seems to support that interpretation: “POLICY PROCEEDINGS OF THE NOVEMBER 2020 MEETING OF! THE AMA ORGANIZED MEDICAL STAFF SECTION RESOLUTIONS”
“15. Resolution 509 – Hydroxychloroquine and Combination Therapies – Off-Label Use
OMSS Action:OMSS Delegate instructed to support the intent of Resolution 509.
HOD Action:Resolution 509 not adopted and Policy H-120.988 reaffirmed.” [Bold Mine]
Sorry folks; based on the above, it looks like the original stories were NOT true.
That’s what I was thinking to say.
The linked source is a resolution.
There’s no citation of it being adopted
There’s a very detailed article on Medpage Today on the resolution and it’s debate but nothing about it actually being voted on and adopted.
A proposed resolution is different from an actual adoption of the resolution.
Although they should.
As one of the doctors spoke (my paraphrase)
Nothing should be off the table in resolving this situation.
CENSORED or pp.com SW bug? I have tried to post a detailed post here, including clips to the article referenced by A1Dukefan in cmt #5, about five times now. And when I hit “Submit”, the post disappears. It originally posted the 1st time, but I went in and did edits, then it disappeared. Attempts to repost after that all disappeared when I hit “Submit”. Wtf? I did see someone else mention something like that happening to them on pp.com though…
Ok, let’s try again…
Here’s the article referenced by A1Dukefan (cmt #5), discussing the resolution to rescind the AMA’s Directive against prescribing HCQ, which was NOT passed. BTW, you’re going to love the title: “AMA Policy Throws Shade on Diehard HCQ Docs”.
Here’s the intro about the resolution that was proposed:
Despite the evidence that has shown that hydroxychloroquine and chloroquine aren’t effective for patients with COVID-19, a frustrated group of physicians are urging the American Medical Association (AMA) to rescind its March statement that discouraged physicians from prescribing the unproven drug for that purpose, even as an early-stage treatment.
This resolution, led by Atlanta rheumatologist John Goldman, MD, an alternate delegate representing the Medical Association of Georgia, was considered at the AMA Special Meeting of its House of Delegates. He said the March statement, issued jointly by the AMA and two pharmacists’ organizations, was hurting physicians’ ability to help patients infected with the virus.
The AMA shouldn’t make statements that interfere with what a physician thinks is best for his or her patients, Goldman and several of his supporters said.
“The combination, if used early, is effective, safe and not expensive, and I’ve had it work in my patients,” Goldman told members of an AMA reference committee on science and public health. “But I’ve had problems getting hydroxychloroquine because pharmacies refuse to dispense it.”
And the response (both against and for):
But Goldman’s proposal was met with fierce opposition during much of the hour devoted to discussing it.
PubMed and Cochrane Library reviews of 4,900 COVID-19 patients “found no benefit from hydroxychloroquine in moderate to severe hospitalized patients,” said Amish Dave, MD, a Seattle rheumatologist and alternate delegate from the Washington State Medical Association. He added that a large-scale randomized controlled trial from the University of Washington, presented at the Infectious Diseases Society of America meeting in October, found “there was no benefit of hydroxychloroquine for post-exposure prophylaxis.”
“I have seen hundreds of patients with lupus, rheumatoid arthritis, Sjogren’s syndrome, and other rheumatic conditions that have needed hydroxychloroquine and have not been able to obtain it during this COVID-19 pandemic, and it’s caused them significant harm, including flares and adverse events,” he said.
“I’m angry that we have to spend our time responding to this and many other statements and distractions that have been made during this pandemic,” said Alan Klitzke, MD, a Buffalo nuclear medicine specialist who represents the American College of Nuclear Medicine.
“Let’s put this in the context of the political environment,” he said, listing President Trump’s claims that hydroxychloroquine works and that he would take it, despite lack of evidence, and other “daily public comments coming from the federal government … blaming a lab in China for releasing an engineered virus, blaming the World Health Organization for failing to stop the virus coming to the U.S. … a widespread U.S. conspiracy about the number of COVID cases that were being reported … (and) claims that hydroxychloroquine would treat this, and doctors could also look into injecting bleach and inserting light sources into the body.”
Not all doctors wanted to toss Goldman’s resolution. A few said that the AMA had no business telling doctors what they should or shouldn’t prescribe.
Robert Frankel, MD, a cardiologist representing the Medical Society of the State of New York, spoke as an individual. He said the AMA’s March statement discouraging doctors from prescribing HCQ was “an extremely slippery slope” — one that undermines the doctor-patient relationship and the ability to prescribe what he or she believes is best for the patient.
“All of us have used FDA-approved drugs and devices in off-label conditions for the benefit of our patients,” he said. He added that physicians have had just 6 or 7 months of experience using the drug for COVID patients, and noted that researchers have rushed to publish those articles, only to retract them later. The FDA also has given emergency use authorization for certain therapies believed to be effective, which were then revoked a few months later.
“We have not exhausted the possibilities of this drug in various different populations and subpopulations for the AMA to determine what is — quote-unquote — appropriate,” Frankel said. “For the AMA to single out this drug was clearly political and inappropriate and I speak strongly in support of this resolution.”